Nerandomilast in Patients with Progressive Pulmonary Fibrosis
Article Details
Journal Info
New England Journal of Medicine
Massachusetts Medical Society
Authors (20)
Toby M. Maher
Shervin Assassi
Arata Azuma
Clinical Research Center, Mihara General Hospital, Saitama, Japan
Vincent Cottin
Université Claude Bernard Lyon 1, Lyon, France
Anna-Maria Hoffmann-Vold
Department of Rheumatology, Oslo University Hospital, Oslo
Michael Kreuter
Center for Pulmonary Medicine, Department of Pneumology, Mainz University Medical Center, Mainz, Germany
Justin M. Oldham
Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor
Luca Richeldi
Unità Operativa Complessa di Pneumologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome
Claudia Valenzuela
Department of Pulmonology, Hospital Universitario de la Princesa, Universidad Autónoma de Madrid, Madrid
Marlies S. Wijsenbeek
Emmanuelle Clerisme-Beaty
Therapy Area Inflammation Medicine, Boehringer Ingelheim International, Ingelheim am Rhein, Germany
Carl Coeck
Boehringer Ingelheim, Brussels
Hui Gu
Department of Chemistry and Chemical Engineering
Ivana Ritter
Therapy Area Inflammation Medicine, Boehringer Ingelheim International, Ingelheim am Rhein, Germany
Arno Schlosser
Clinical Development Operations, Boehringer Ingelheim, Amsterdam
Susanne Stowasser
Therapy Area Inflammation Medicine, Boehringer Ingelheim International, Ingelheim am Rhein, Germany
Florian Voss
Global Biostatistics and Data Sciences, Boehringer Ingelheim Pharma, Ingelheim am Rhein, Germany
Gerrit Weimann
Therapy Area Inflammation Medicine, Boehringer Ingelheim International, Ingelheim am Rhein, Germany
Donald F. Zoz
Global Clinical Development and Medical Affairs, Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT
Fernando J. Martinez